Daniel Loeb’s Labcorp LH Stock Holding History

Daniel Loeb’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-223,634	Closed	-$45.2M	–	49
2022 Q4	$45.2M	Buy	+223,634	New	+$43.7M	0.76%	18

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Daniel Loeb's LH Position: Q1 2023 in Review

Daniel Loeb sold out of Labcorp (LH) in Q1 2023, closing a stake of 223,634 shares — an estimated $45.2M sold.

Daniel Loeb first reported a position in LH in Q4 2022 and held it in 1 quarter. The position peaked at $45.2M in Q4 2022. 941 funds tracked by Wall St. Rank hold LH as of Q1 2023.

Daniel Loeb reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
Daniel Loeb sold 223,634 Labcorp shares in Q1 2023, an estimated $45.2M.
Daniel Loeb first reported a position in Labcorp in Q4 2022 and held it in 1 quarter.
Daniel Loeb's Labcorp position peaked at $45.2M in Q4 2022.
941 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Third Point's 13F filing for Q1 2023, filed 15 May 2023.